Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
Pair these drug administration codes with D50.0 or D50.8 for the best reimbursement results
The pharmacological consequence is that a single injection of CJC-1295 with DAC produces sustained GH elevation for days rather than the hours-long pulse from the non-DAC version
The lipids (oily fatty acids) form our cell membranes so that their non-polar tails face inward away from the polar cytoplasm and the polar heads face towards the polar cytoplasm
Frequently asked questions Why is 5-amino-1MQ sold alongside peptides if it is not one
References Journal of Endocrinology & Metabolism (2014) Safety and metabolism of AOD9604: novel nutraceutical ingredient for improved metabolic health Journal of Clinical Endocrinology & Metabolism (PubMed) Prolonged stimulation of GH and IGF-I secretion by CJC-1295 in healthy adults European Journal of Endocrinology (PubMed) Ipamorelin: the first selective growth hormone secretagogue Translational Andrology and Urology (PMC) Role of growth hormone secretagogues in body composition management Endocrinology (OUP) hGH and AOD-9604: lipid metabolism and beta-adrenergic pathway insights CDC Preventing unsafe injection practices: multi-dose vial handling guidelines Journal of Endocrinology & Metabolism (2013) Safety and tolerability of the hexadecapeptide AOD9604 in humans Obesity Pharmacotherapy Review (PMC) AOD-9604 clinical trial overview and weight loss outcomes Subcutaneous Drug Injection Review (PMC) Pharmacologic considerations of the subcutaneous route CDC Vaccine administration: subcutaneous route (angle/site guidance) MedlinePlus Subcutaneous injections: patient instructions and technique NCBI Bookshelf Best practices for injection: asepsis, preparation, and administration Additional Research and Background These sources provide related context and are not presented as support for a specific statement above
US$ 21.28
US$ 23.69
US$ 21.45
US$ 29.01
US$ 28.47
US$ 28.62
